-
Mashup Score: 0
Neuromod Devices announced today that it closed a $33.2 million (€30 million) financing round to support its tinnitus treatment device.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Is blood-brain barrier a probable mediator of non-invasive brain stimulation effects on Alzheimer’s disease? - Communications Biology - 1 year(s) ago
Evidence from in vitro experiments, animal models and humans is revisited and highlights the potential role of the blood-brain barrier in mediating the effects of non-invasive brain stimulation in AD.
Source: NatureCategories: Healthcare Professionals, Latest HeadlinesTweet-
PERSPECTIVE: Is blood-brain #barrier a probable mediator of non-invasive #brain stimulation effects on #Alzheimer’s disease? https://t.co/tgj7CnB6Sa @CommsBio #NIBS #TMS #tDCS #BBB permeability: a double-edged sword. How is it impacted by #neuromodulation, and how does the… https://t.co/xpV1rVOgdt https://t.co/QvbSKiHVen
-
-
Mashup Score: 1Neuromodulation: Technology at the Neural Interface | Journal | ScienceDirect.com by Elsevier - 1 year(s) ago
Read the latest articles of Neuromodulation: Technology at the Neural Interface at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature
Source: www.sciencedirect.comCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0
Reach Neuro announced today that it received FDA breakthrough device designation for its Avantis platform for restoring movement.
Source: MassDeviceCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The company’s product, Prism, uses neurofeedback to help PTSD patients learn to control their emotional response.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Neurotechnology company Cognito Therapeutics scores $73M - 1 year(s) ago
The company will use the funds to advance the study of its neuromodulation device intended to treat Alzheimer’s disease.
Source: MobiHealthNewsCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
The patient-administered device, which uses a mild electrical current to improve depressive symptoms, showed promising results in a clinical trial.
Source: MedTech DiveCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0
In a prospective, randomized clinical trial, researchers evaluated the efficacy and safety of REN, applied every other day, for the prevention of migraine.
Source: Neurology AdvisorCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 0Home – Cell Symposium: Neurometabolism in Health and Disease - 1 year(s) ago
Cell Symposium: Neurometabolism in Health and Disease
Source: cell-symposia.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Frontiers in Neuroimaging | Neuroimaging and Neuromodulation - 1 year(s) ago
Advances neuroimaging and neuromodulation techniques to improve diagnostics, treatment and technologies
Source: FrontiersCategories: Latest Headlines, NeurologyTweet-
It is our pleasure to announce the launch of a new specialty section: Neuroimaging and Neuromodulation led by Prof. Vladimir Litvak of UCL. The section covers all experimental and theoretical research related to #neuroimaging #neuromodulation. More info: https://t.co/cFGR5oJIKl https://t.co/7vfi5EiJUw
-
.@NeuromodDevices closes $33.2M financing for #tinnitus-treating #neuromodulation tech https://t.co/ksHd7gTkHi